Endovia Health Sciences (EDVA) Total Current Liabilities (2011 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Total Current Liabilities (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 2.53 Bn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 354.06 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 2.12 Bn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 1.51 Bn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | 630.93 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 16.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.83 Mn |
| Mar 31, 2026 | 16.97 Mn |
| Dec 31, 2025 | 16.26 Mn |
| Sep 30, 2025 | 15.64 Mn |
| Jun 30, 2025 | 13.45 Mn |
| Mar 31, 2025 | 20.42 Mn |
| Dec 31, 2024 | 19.37 Mn |
| Sep 30, 2024 | 17.78 Mn |
| Jun 30, 2024 | 16.82 Mn |
| Mar 31, 2024 | 17.02 Mn |
| Dec 31, 2023 | 14.75 Mn |
| Sep 30, 2023 | 11.13 Mn |
| Jun 30, 2023 | 8.56 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 4.97 Mn |
| Sep 30, 2022 | 5.19 Mn |
| Jun 30, 2022 | 4.46 Mn |
| Mar 31, 2022 | 5.43 Mn |
| Dec 31, 2021 | 6.48 Mn |
| Sep 30, 2021 | 5.59 Mn |